These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11123912)
1. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site. Weber T; Schaffhausen B; Liu Y; Günther UL Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912 [TBL] [Abstract][Full Text] [Related]
2. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes. Kristensen SM; Siegal G; Sankar A; Driscoll PC J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283 [TBL] [Abstract][Full Text] [Related]
3. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase. Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure and NMR studies of the apo SH2 domains of ZAP-70: two bikes rather than a tandem. Folmer RH; Geschwindner S; Xue Y Biochemistry; 2002 Dec; 41(48):14176-84. PubMed ID: 12450381 [TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402 [TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance structure of the P395S mutant of the N-SH2 domain of the p85 subunit of PI3 kinase: an SH2 domain with altered specificity. Günther UL; Weyrauch B; Zhang X; Schaffhausen B Biochemistry; 2003 Sep; 42(38):11120-7. PubMed ID: 14503862 [TBL] [Abstract][Full Text] [Related]
7. Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides. Suenaga A; Takada N; Hatakeyama M; Ichikawa M; Yu X; Tomii K; Okimoto N; Futatsugi N; Narumi T; Shirouzu M; Yokoyama S; Konagaya A; Taiji M J Biol Chem; 2005 Jan; 280(2):1321-6. PubMed ID: 15520002 [TBL] [Abstract][Full Text] [Related]
8. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study. Bradshaw JM; Grucza RA; Ladbury JE; Waksman G Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054 [TBL] [Abstract][Full Text] [Related]
9. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide. Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001 [TBL] [Abstract][Full Text] [Related]
10. NMRKIN: simulating line shapes from two-dimensional spectra of proteins upon ligand binding. Günther UL; Schaffhausen B J Biomol NMR; 2002 Mar; 22(3):201-9. PubMed ID: 11991351 [TBL] [Abstract][Full Text] [Related]
11. Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain. Nachman J; Gish G; Virag C; Pawson T; Pomès R; Pai E PLoS One; 2010 Jun; 5(6):e11215. PubMed ID: 20574521 [TBL] [Abstract][Full Text] [Related]
12. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978 [TBL] [Abstract][Full Text] [Related]
13. Tracing kinetic intermediates during ligand binding. Mittag T; Schaffhausen B; Günther UL J Am Chem Soc; 2004 Jul; 126(29):9017-23. PubMed ID: 15264834 [TBL] [Abstract][Full Text] [Related]
14. Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide. Tsuchiya S; Ogura K; Hatanaka H; Nagata K; Terasawa H; Mandiyan V; Schlessinger J; Aimoto S; Ohta H; Inagaki F J Biochem; 1999 Jun; 125(6):1151-9. PubMed ID: 10348919 [TBL] [Abstract][Full Text] [Related]
15. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Domchek SM; Auger KR; Chatterjee S; Burke TR; Shoelson SE Biochemistry; 1992 Oct; 31(41):9865-70. PubMed ID: 1382595 [TBL] [Abstract][Full Text] [Related]
17. Alternative modes of binding of proteins with tandem SH2 domains. O'Brien R; Rugman P; Renzoni D; Layton M; Handa R; Hilyard K; Waterfield MD; Driscoll PC; Ladbury JE Protein Sci; 2000 Mar; 9(3):570-9. PubMed ID: 10752619 [TBL] [Abstract][Full Text] [Related]
18. NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites. Günther UL; Liu Y; Sanford D; Bachovchin WW; Schaffhausen B Biochemistry; 1996 Dec; 35(48):15570-81. PubMed ID: 8952511 [TBL] [Abstract][Full Text] [Related]
19. Calorimetric investigation of proton linkage by monitoring both the enthalpy and association constant of binding: application to the interaction of the Src SH2 domain with a high-affinity tyrosyl phosphopeptide. Bradshaw JM; Waksman G Biochemistry; 1998 Nov; 37(44):15400-7. PubMed ID: 9799501 [TBL] [Abstract][Full Text] [Related]
20. Electrostatic interactions in the reconstitution of an SH2 domain from constituent peptide fragments. Ojennus DD; Lehto SE; Wuttke DS Protein Sci; 2003 Jan; 12(1):44-55. PubMed ID: 12493827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]